Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 49


Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4.

Todaro M, Alea MP, Di Stefano AB, Cammareri P, Vermeulen L, Iovino F, Tripodo C, Russo A, Gulotta G, Medema JP, Stassi G.

Cell Stem Cell. 2007 Oct 11;1(4):389-402. doi: 10.1016/j.stem.2007.08.001.


Identification of cells initiating human melanomas.

Schatton T, Murphy GF, Frank NY, Yamaura K, Waaga-Gasser AM, Gasser M, Zhan Q, Jordan S, Duncan LM, Weishaupt C, Fuhlbrigge RC, Kupper TS, Sayegh MH, Frank MH.

Nature. 2008 Jan 17;451(7176):345-9. doi: 10.1038/nature06489.


Comment on "Tumor growth need not be driven by rare cancer stem cells".

Kennedy JA, Barabé F, Poeppl AG, Wang JC, Dick JE.

Science. 2007 Dec 14;318(5857):1722; author reply 1722.


The fuzzy math of solid tumor stem cells: a perspective.

Kern SE, Shibata D.

Cancer Res. 2007 Oct 1;67(19):8985-8.


Breast cancer stem cells: a case of mistaken identity?

Polyak K.

Stem Cell Rev. 2007 Jun;3(2):107-9. Review. No abstract available.


Tumor growth need not be driven by rare cancer stem cells.

Kelly PN, Dakic A, Adams JM, Nutt SL, Strasser A.

Science. 2007 Jul 20;317(5836):337.


Epithelial-mesenchymal transition and colorectal cancer: gaining insights into tumor progression using LIM 1863 cells.

Bates RC, Pursell BM, Mercurio AM.

Cells Tissues Organs. 2007;185(1-3):29-39. Review.


Phenotypic characterization of human colorectal cancer stem cells.

Dalerba P, Dylla SJ, Park IK, Liu R, Wang X, Cho RW, Hoey T, Gurney A, Huang EH, Simeone DM, Shelton AA, Parmiani G, Castelli C, Clarke MF.

Proc Natl Acad Sci U S A. 2007 Jun 12;104(24):10158-63. Epub 2007 Jun 4.


Myc deletion rescues Apc deficiency in the small intestine.

Sansom OJ, Meniel VS, Muncan V, Phesse TJ, Wilkins JA, Reed KR, Vass JK, Athineos D, Clevers H, Clarke AR.

Nature. 2007 Apr 5;446(7136):676-9. Epub 2007 Mar 21.


c-Myb is required for progenitor cell homeostasis in colonic crypts.

Malaterre J, Carpinelli M, Ernst M, Alexander W, Cooke M, Sutton S, Dworkin S, Heath JK, Frampton J, McArthur G, Clevers H, Hilton D, Mantamadiotis T, Ramsay RG.

Proc Natl Acad Sci U S A. 2007 Mar 6;104(10):3829-34. Epub 2007 Feb 26.


Molecular definition of breast tumor heterogeneity.

Shipitsin M, Campbell LL, Argani P, Weremowicz S, Bloushtain-Qimron N, Yao J, Nikolskaya T, Serebryiskaya T, Beroukhim R, Hu M, Halushka MK, Sukumar S, Parker LM, Anderson KS, Harris LN, Garber JE, Richardson AL, Schnitt SJ, Nikolsky Y, Gelman RS, Polyak K.

Cancer Cell. 2007 Mar;11(3):259-73.


Establishment of human colon cancer cell lines from fresh tumors versus xenografts: comparison of success rate and cell line features.

Dangles-Marie V, Pocard M, Richon S, Weiswald LB, Assayag F, Saulnier P, Judde JG, Janneau JL, Auger N, Validire P, Dutrillaux B, Praz F, Bellet D, Poupon MF.

Cancer Res. 2007 Jan 1;67(1):398-407.


A human colon cancer cell capable of initiating tumour growth in immunodeficient mice.

O'Brien CA, Pollett A, Gallinger S, Dick JE.

Nature. 2007 Jan 4;445(7123):106-10. Epub 2006 Nov 19.


Identification and expansion of human colon-cancer-initiating cells.

Ricci-Vitiani L, Lombardi DG, Pilozzi E, Biffoni M, Todaro M, Peschle C, De Maria R.

Nature. 2007 Jan 4;445(7123):111-5. Epub 2006 Nov 19.


Glioma stem cells promote radioresistance by preferential activation of the DNA damage response.

Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, Hjelmeland AB, Dewhirst MW, Bigner DD, Rich JN.

Nature. 2006 Dec 7;444(7120):756-60. Epub 2006 Oct 18.


Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells.

Clarke MF, Dick JE, Dirks PB, Eaves CJ, Jamieson CH, Jones DL, Visvader J, Weissman IL, Wahl GM.

Cancer Res. 2006 Oct 1;66(19):9339-44. Epub 2006 Sep 21. No abstract available.


Rapid loss of intestinal crypts upon conditional deletion of the Wnt/Tcf-4 target gene c-Myc.

Muncan V, Sansom OJ, Tertoolen L, Phesse TJ, Begthel H, Sancho E, Cole AM, Gregorieff A, de Alboran IM, Clevers H, Clarke AR.

Mol Cell Biol. 2006 Nov;26(22):8418-26. Epub 2006 Sep 5.


Strategies to eliminate cancer stem cells: clinical implications.

Huff CA, Matsui WH, Smith BD, Jones RJ.

Eur J Cancer. 2006 Jun;42(9):1293-7. Epub 2006 Apr 27. Review.


RNAi-mediated knockdown of aldehyde dehydrogenase class-1A1 and class-3A1 is specific and reveals that each contributes equally to the resistance against 4-hydroperoxycyclophosphamide.

Moreb JS, Mohuczy D, Ostmark B, Zucali JR.

Cancer Chemother Pharmacol. 2007 Jan;59(1):127-36. Epub 2006 Apr 14. Erratum in: Cancer Chemother Pharmacol. 2007 Jan;59(1):137. Muhoczy, Dagmara [corrected to Mohuczy, Dagmara].


Supplemental Content

Support Center